Tolmar - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsTolmar

Tolmar

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Eligard	Leuprolide	2002-01-23	2023-2041	Prostatic neoplasms , Breast neoplasms , Ovarian neoplasms , Endometrial neoplasms , Prostatic hyperplasia , Leiomyoma , Endometriosis , Infertility , Precocious puberty , Menorrhagia , Acne vulgaris , Endometrial hyperplasia , Hypogonadism
Fensolvi	Leuprolide	2020-05-01	2023-2041	Prostatic neoplasms , Breast neoplasms , Ovarian neoplasms , Endometrial neoplasms , Prostatic hyperplasia , Leiomyoma , Endometriosis , Infertility , Precocious puberty , Menorrhagia , Acne vulgaris , Endometrial hyperplasia , Hypogonadism
Jatenzo	Testosterone undecanoate	2019-03-27	2026-2041	Breast neoplasms , Hypogonadism , Delayed puberty , Prostatic neoplasms , Menorrhagia , Primary ovarian insufficiency , Hot flashes , Premature menopause
Levetiracetam	Levetiracetam	2009-01-15	2026-2034	Epilepsy, Juvenile myoclonic epilepsy, Partial epilepsies, Tonic-clonic epilepsy
Ranitidine	Ranitidine	2010-11-15		Gastroesophageal reflux, Peptic esophagitis, Stomach ulcer, Duodenal ulcer, Zollinger-ellison syndrome

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

breast neoplasms

,

precocious puberty

Testosterone undecanoate

breast neoplasms

Microcrystalline cellulose

breast neoplasms

breast neoplasms

breast neoplasms

,

precocious puberty

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use